- Bayer to 'accelerate' five drug candidates and expand on recent launches
- FDA HCV ‘hold’ pattern continues: Vertex VX-135 hit
- PharmAthene investors breathe easier after FDA lifts SparVax hold
- US Capitol Capsule: FDA barks about state restrictions, but where's the bite?
COMMENT Other Informa Comment